Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9465

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 0143-9465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Daptomycin Cc Premierprorx 1)

A table presenting recommended dosages of Daptomycin injection for pediatric patients aged 1 to 17 years with cSSSI, based on age groups. It lists dosage regimens in mg/kg with infusion times, and therapy duration up to 14 days, noting recommendation applies to patients with normal renal function.*

FDA Label Image

Table 2 (Daptomycin Cc Premierprorx 2)

A data table showing recommended dosage of Daptomycin injection for pediatric patients aged 1 to 17 years with S. aureus bacteremia. It details dosage amounts per age group (1-6 years, 7-11 years, 12-17 years), infusion duration, and therapy duration up to 42 days, with a note on dosage adjustments for renal function.*

FDA Label Image

Table 3 (Daptomycin Cc Premierprorx 3)

Table titled 'Recommended Dosage of Daptomycin for Injection in Adult Patients' showing dosage regimens based on creatinine clearance. It compares dosages for cSSSI and S. aureus bloodstream infections, indicating different dosing intervals for patients with creatinine clearance greater or equal to 30 mL/min versus those with less than 30 mL/min, including hemodialysis and CAPD.*

FDA Label Image

Chemical Structure (Daptomycin Cc Premierprorx 4)

Chemical structure of daptomycin, a cyclic lipopeptide antibiotic molecule with multiple peptide bonds and a characteristic lipid tail, as depicted in the image.*

FDA Label Image

Premier Pro Rx (Daptomycin Cc Premierprorx 5)

FDA Label Image

Unit Label (Daptomycin Cc Premierprorx 6)

Label for Daptomycin for Injection 500 mg/vial, lyophilized powder for intravenous infusion. The label indicates the product must be refrigerated at 2°C to 8°C (36°F to 46°F). It is a single-dose vial for injection, with unused portion to be discarded. The product is manufactured for Xellia Pharmaceuticals Inc and distributed by Hikma Pharmaceuticals USA Inc. Made in India.*

FDA Label Image

Carton (Daptomycin Cc Premierprorx 7)

Packaging label for Daptomycin for Injection 500 mg/vial, a lyophilized powder for intravenous injection. The label features the proprietary name prominently on a blue background with dosing strength, storage instructions to refrigerate, and manufacturer information including Hikma Pharmaceuticals USA Inc. and Xellia Pharmaceuticals Inc. The label states this is a prescription-only product and includes instructions for reconstitution with 10 mL of 0.9% Sodium Chloride Injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.